Xarelto Vs. Eliquis for a female patient aged 71 - from FDA reports


Summary

This is a personalized comparison Xarelto, Eliquis for a woman aged 71. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>



On Nov, 17, 2017

11,029 females aged 71 (±5) who take Xarelto, Eliquis are studied.

Number of reports submitted per year:

Xarelto, Eliquis for a female patient aged 71.

Information of the patient in this study:

  • Age: 71
  • Gender: female
  • Reason for the study: Atrial Flutter

Drugs in this study:

  • Xarelto (rivaroxaban)
  • Eliquis (apixaban)

eHealthMe real world results for females aged 71 (±5):

Comparison with the specified adverse outcomes:
Outcome and its % of total reports:

Loss Of Balance:
  • Xarelto: 2.49 %
  • Eliquis: 1.18 %
Weakness:
  • Xarelto: 2.33 %
  • Eliquis: 0.98 %
Confusion:
  • Xarelto: 0.05 %
  • Eliquis: 0.04 %
Abnormal Weight Gain:
  • Xarelto: 0.03 %
  • Eliquis: 0.0 %

Most common side effects:

Xarelto:
  • Anaemia
  • Breathing Difficulty
  • Drug Ineffective
  • Fall
  • Gastrointestinal Haemorrhage
  • Haemorrhage
  • Nosebleed
  • Pulmonary Embolism
  • Rectal Haemorrhage
  • Upper Gastrointestinal Haemorrhage
Eliquis:
  • Breathing Difficulty
  • Death
  • Diarrhea
  • Fall
  • Fatigue
  • Gastrointestinal Haemorrhage
  • Haemorrhage
  • Headache
  • Nausea
  • Nosebleed

Most common side effects experienced by people in long term use:

Xarelto:
  • Anaemia
  • Cerebral Haemorrhage
  • Fall
  • Gastrointestinal Haemorrhage
  • Haematuria
  • Haemorrhage
  • Lower Gastrointestinal Haemorrhage
  • Nosebleed
  • Rectal Haemorrhage
  • Upper Gastrointestinal Haemorrhage
Eliquis:
  • Brain Surgery
  • Cerebral Haemorrhage
  • Cerebral Infarction
  • Fall
  • Gastrointestinal Haemorrhage
  • Gingival Bleeding
  • Haematuria
  • Increased Tendency To Bruise
  • Pancreatic Carcinoma
  • Surgery

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

What are the symptoms?

Related studies:

Can you answer these questions?

More questions for: Xarelto, Eliquis

You may be interested in these reviews

More reviews for: Xarelto, Eliquis